The Platelet Rich Plasma Market size was worth US$ 370.78 million in 2021. Because of a favourable demand outlook, the market is expected to increase at a steady 6% CAGR until 2031. According to a Platelet Rich Plasma analysis published by Future Market Insights (FMI), growth prospects remain positive as PLATELET RICH PLASMA therapy gains popularity in a variety of medical procedures, including cosmetic, orthopaedic, and neurological surgery.
Get Sample Report + Related Graphs & Charts@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1722
The report’s market overview section includes a qualitative analysis of the overall PLATELET RICH PLASMA market, taking into account the variables influencing market dynamics such as drivers, constraints, and opportunities, as well as Porter’s five force analysis and market attractiveness analysis. Various analyses, such as event effect analysis, regulatory scenario analysis, and value chain analysis, have also been offered. Event impact study includes key events that occurred in the previous decade and are predicted to occur during the forecast period, with the potential to alter market dynamics positively or negatively. The investigation of important phases involved in the preparation and dissemination of PLATELET RICH PLASMA devices is included in the value chain analysis. Regulatory scenario includes the study of different regulatory norms and procedures that regulate the approval and commercialization of PLATELET RICH PLASMA devices and products.
Key Takeaways
- According to FMI, an ESOMAR-certified consulting business, the United States is expected to increase at a 4.5% CAGR between 2021 and 2031.
- The platelet-rich plasma market in the United Kingdom is expected to grow at a 5.4% CAGR.
- PRP-based treatments are gaining traction in Germany, outpacing complicated cell-based therapies.
- Pure platelet-rich plasma is predicted to account for the majority of sales due to benefits such as improved wound healing, tissue repair and regeneration, and cost-effectiveness, according to FMI’s recent market assessment.
- Autologous PRPs are projected to generate excellent returns based on origin, with expanding applications in the treatment of diabetic chronic nonhealing wounds.
- Cosmetic procedures will continue to dominate the application category during the projected period, thanks to developments and the introduction of improved PRP treatments in cosmetology.
For critical insights on this market, request to ask an expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-1722
Competitive Landscape
The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global PLATELET RICH PLASMA market, in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. The report concludes with the profiles of major players in the global PLATELET RICH PLASMA market such as AdiStem Ltd., Arteriocyte Medical Systems, Inc., Arthrex, Inc., Biomet, Inc., Cesca Therapeutics, Inc., DePuy Synthes, Inc., Dr. PLATELET RICH PLASMA America LLC., EmCyte Corporation, Exactech, Inc., Harvest Technologies Corp., Nuo Therapeutics, Inc., Regen Lab SA, and Stryker Corporation. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.
- Zimmer Biomet Holdings Inc., a global leader in musculoskeletal healthcare, established a strategic agreement with OSSIS, a New Zealand-based firm that specialises in hip replacement treatments, in July 2021. The collaboration’s goal was to promote Zimmer Biomet’s patient-specific 3D printed titanium hip replacement joints in Asia-Pacific. The collaboration will help Zimmer Biomet expand its product offering of hip replacement options and other complimentary technologies.
- Regen Lab SA stated in May 2019 that it had received additional US patents covering its Thrombin Serum (TS), Platelet Rich Plasma (PRP), and Hyaluronic Acid (HA) technologies.
For in-depth competitive analysis, Buy Now@ https://www.futuremarketinsights.com/checkout/1722
Global Platelet Rich Plasma Market is segmented as follows:
- Global Platelet Rich Plasma Market, by Types
- Pure-Platelet Rich Plasma (P-PLATELET RICH PLASMA)
- Leukocyte-Platelet Rich Plasma (L-PLATELET RICH PLASMA)
- Leukocyte-Platelet Rich Fibrin (L-PRF)
- Global Platelet Rich Plasma Market, by Origin
- Autologus
- Homologus
- Allogenic
- Global Platelet Rich Plasma Market, by Applications
- Orthopedic Surgery
- Cosmetic Surgery
- General Surgery
- Neurosurgery
- Other Surgeries (Urological, Cardiothoracic, Periodontal and Oral and Maxillofacial)
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs